Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ICPT Intercept Pharmaceuticals Inc

19,00

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Intercept Pharmaceuticals Charts.

Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Intercept Pharmaceuticals Charts.

News Intercept Pharmaceuticals Inc

Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
Donnerstag 29 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 20 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 15 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere Intercept Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen